Vol. 28.Issue. 1. January - February 2023 | Annals of Hepatology

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Buscar en

Annals of Hepatology

Toda la web

Inicio Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2022

3.8

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2022

6.3

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2022

0.859

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2022

0.989

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 28. Issue 1.

(January - February 2023)

Editorial board

Ann Hepatol. 2023;28:100895

Open access

Editorials

Change of courier for Annals of Hepatology

Norberto Chávez-Tapia

Ann Hepatol. 2023;28:100893

Open access

Opinions

The treatment of diabetes in advanced liver disease: change of a paradigm

Maria Letizia Petroni, Lucia Brodosi, Giulio Marchesini

Ann Hepatol. 2023;28:100772

Open access

Concise reviews

Immunotolerance in liver transplantation: a primer for the clinician

Juanita Pérez-Escobar, Jose Victor Jimenez, Erika Faride Rodríguez-Aguilar, Maximiliano Servín-Rojas, Jesus Ruiz-Manriquez, Luisa Safar-Boueri, Eduardo Carrillo-Maravilla, Miquel Navasa, Ignacio García-Juárez

Ann Hepatol. 2023;28:100760

Open access

A thorny matter: Spur cell anemia

Ruchi Sharma, Carol J. Holman, Kyle E. Brown

Ann Hepatol. 2023;28:100771

Open access

Original articles

Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver

Cristiane A. Villela-Nogueira, Maria Lúcia Gomes Ferraz, Mário Guimarães Pessoa, Francisco José Dutra Souto, Letícia Cancella Nabuco, Henrique Sérgio Moraes Coelho, Ezequiel Ridruejo, Marcelo Silva, ... Members of the Brazilian Society of Hepatology

Ann Hepatol. 2023;28:100764

Open access

Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients

Haohui Deng, Yuzhen Mai, Huiyuan Liu, Jialong Guan

Ann Hepatol. 2023;28:100763

Open access

Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis

Mark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, ... Mazen Noureddin

Ann Hepatol. 2023;28:100762

Open access

Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study

Samantha Thifani Alrutz Barcelos, Amanda Souza Silva-Sperb, Helena Abadie Moraes, Larisse Longo, Bruna Concheski de Moura, Matheus Truccolo Michalczuk, Carolina Uribe-Cruz, Carlos Thadeu Schmidt Cerski, ... Mário Reis Álvares-da-Silva

Ann Hepatol. 2023;28:100769

Open access

Liver steatosis and fibrosis markers’ association with cardiovascular and renal damage in Japanese adults: the TMM BirThree cohort study

Toshiya Machida, Taku Obara, Mami Ishikuro, Keiko Murakami, Fumihiko Ueno, Aoi Noda, Tomomi Onuma, Fumiko Matsuzaki, ... Nariyasu Mano

Ann Hepatol. 2023;28:100761

Open access

Magnitude and genotype of hepatitis delta virus among chronic hepatitis B carriers with a spectrum of liver diseases in Ethiopia

Yayehyirad Tassachew, Yeshambel Belyhun, Tamrat Abebe, Adane Mihret, Tezazu Teffera, Girma Ababi, Abate Shewaye, Hailemichael Desalegn, ... Melanie Maier

Ann Hepatol. 2023;28:100770

Open access

HOXB13 facilitates hepatocellular carcinoma progression by activating AKT/mTOR signaling pathway

Miao Li, Tingting Tan, Yu Geng, Yue Tao, Jie Pan, Jun Zhang, Qin Xu, Han Shen, ... Yuxin Chen

Ann Hepatol. 2023;28:100759

Open access

Testicular orphan receptor 4 induced hepatic stellate cells activation via the regulation of TGF-β receptor Ⅰ/Smad2/3 signaling pathway

Yadong Fu, Yuping Zhou, Yongping Mu, Ying Lv, Gaofeng Chen, Hua Zhang, Ping Liu, Jiamei Chen

Ann Hepatol. 2023;28:100775

Open access

New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD

Louise Torres, Alice Schuch, Larisse Longo, Bruna Bressan Valentini, Gabriela Schneider Galvão, Eduardo Luchese, Carlos Pinzon, Rodrigo Bartels, Mário Reis Álvares-da-Silva

Ann Hepatol. 2023;28:100774

Open access

Letters to the editor

Interpretive bias on research evidence: Striving to meet the trustworthiness criteria

Nahum Méndez-Sánchez, Eduardo Fassio, Shreya C. Pal

Ann Hepatol. 2023;28:100884

Open access

MAFLD vs. NAFLD not an emotional political process - rather Evidence-Based Medicine

Mark Muthiah, Arun J. Sanyal, Mazen Noureddin

Ann Hepatol. 2023;28:100883

Open access

Special issue on genomic medicine in obesity and chronic liver damage

Genomic medicine in hepatology: Towards personalized medicine in obesity and chronic liver disease

Sonia Roman, Omar Ramos-Lopez, Arturo Panduro

Ann Hepatol. 2023;28:100875

Open access

Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH

Eduardo E. Vargas-Pozada, Erika Ramos-Tovar, Juan D. Rodriguez-Callejas, Irina Cardoso-Lezama, Silvia Galindo-Gómez, Karla Gil-Becerril, Verónica Rocío Vásquez-Garzón, Jaime Arellanes-Robledo, ... Pablo Muriel

Ann Hepatol. 2023;28:100780

Open access

Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysis

Daniela Contreras, Alejandra González-Rocha, Patricia Clark, Simón Barquera, Edgar Denova-Gutiérrez

Ann Hepatol. 2023;28:100873

Open access

What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?

Ingrid Rivera-Iñiguez, Arturo Panduro, Sonia Roman, Karina González-Aldaco

Ann Hepatol. 2023;28:100874

Open access

Body mass index implications in intrahepatic cholestasis of pregnancy and placental histopathological alterations

Violeta Valdovinos-Bello, Carmen Selene García-Romero, Alicia Cervantes-Peredo, Elizabeth García-Gómez, Alejandra Martínez-Ibarra, Edgar Ricardo Vázquez-Martínez, Yolotzin Valdespino, Marco Cerbón

Ann Hepatol. 2023;28:100879

Open access